2ERJ | pdb_00002erj

Crystal structure of the heterotrimeric interleukin-2 receptor in complex with interleukin-2


Experimental Data Snapshot

  • Method:&nbspX-RAY DIFFRACTION
  • Resolution:&nbsp3.00 Å
  • R-Value Free:&nbsp
    0.263 (Depositor), 0.220 (DCC)&nbsp
  • R-Value Work:&nbsp
    0.220 (Depositor), 0.220 (DCC)&nbsp
  • R-Value Observed:&nbsp
    0.223&nbsp(Depositor)&nbsp

Starting Model: experimental
View more details

wwPDB Validation&nbsp &nbsp3D Report&nbspFull Report


Ligand Structure Quality Assessment&nbsp


This is version 2.3 of the entry. See complete&nbsphistory.&nbsp


Literature

Crystal structure of the IL-2 signaling complex: Paradigm for a heterotrimeric cytokine receptor.

Stauber, D.J.,&nbspDebler, E.W.,&nbspHorton, P.A.,&nbspSmith, K.A.,&nbspWilson, I.A.

(2006) Proc Natl Acad Sci U S A&nbsp103: 2793

  • DOI:&nbsphttps://doi.org/10.1073/pnas.0511161103
  • Primary Citation of Related Structures: &nbsp
    2ERJ

  • PubMed Abstract:&nbsp

    IL-2 is a cytokine that functions as a growth factor and central regulator in the immune system and mediates its effects through ligand-induced hetero-trimerization of the receptor subunits IL-2R alpha, IL-2R beta, and gamma(c). Here, we describe the crystal structure of the trimeric assembly of the human IL-2 receptor ectodomains in complex with IL-2 at 3.0 A resolution. The quaternary structure is consistent with a stepwise assembly from IL-2/IL-2R alpha to IL-2/IL-2R alpha/IL-2R beta to IL-2/IL-2R alpha/IL-2R beta/gamma(c). The IL-2R alpha subunit forms the largest of the three IL-2/IL-2R interfaces, which, together with the high abundance of charge-charge interactions, correlates well with the rapid association rate and high-affinity interaction of IL-2R alpha with IL-2 at the cell surface. Surprisingly, IL-2R alpha makes no contacts with IL-2R beta or gamma(c), and only minor changes are observed in the IL-2 structure in response to receptor binding. These findings support the principal role of IL-2R alpha to deliver IL-2 to the signaling complex and act as regulator of signal transduction. Cooperativity in assembly of the final quaternary complex is easily explained by the extraordinarily extensive set of interfaces found within the fully assembled IL-2 signaling complex, which nearly span the entire length of the IL-2R beta and gamma(c) subunits. Helix A of IL-2 wedges tightly between IL-2R beta and gamma(c) to form a three-way junction that coalesces into a composite binding site for the final gamma(c) recruitment. The IL-2/gamma(c) interface itself exhibits the smallest buried surface and the fewest hydrogen bonds in the complex, which is consistent with its promiscuous use in other cytokine receptor complexes.


  • Organizational Affiliation:&nbsp

    Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Interleukin-2 receptor alpha chain
A, E
225Homo sapiensMutation(s): 2&nbsp
Gene Names:&nbspIL2RA
UniProt & NIH Common Fund Data Resources
Find proteins for&nbspP01589&nbsp(Homo sapiens)
Explore&nbspP01589&nbsp
Go to UniProtKB: &nbspP01589
PHAROS: &nbspP01589
GTEx: &nbspENSG00000134460&nbsp
Entity Groups &nbsp
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP01589
Sequence Annotations
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 2
MoleculeChains Sequence LengthOrganismDetailsImage
Interleukin-2 receptor beta chain
B, F
219Homo sapiensMutation(s): 0&nbsp
Gene Names:&nbspIL2RB
UniProt & NIH Common Fund Data Resources
Find proteins for&nbspP14784&nbsp(Homo sapiens)
Explore&nbspP14784&nbsp
Go to UniProtKB: &nbspP14784
PHAROS: &nbspP14784
GTEx: &nbspENSG00000100385&nbsp
Entity Groups &nbsp
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP14784
Glycosylation
Glycosylation Sites: 3Go to GlyGen: P14784-1
Sequence Annotations
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 3
MoleculeChains Sequence LengthOrganismDetailsImage
Cytokine receptor common gamma chain
C, G
247Homo sapiensMutation(s): 1&nbsp
Gene Names:&nbspIL2RG
UniProt & NIH Common Fund Data Resources
Find proteins for&nbspP31785&nbsp(Homo sapiens)
Explore&nbspP31785&nbsp
Go to UniProtKB: &nbspP31785
PHAROS: &nbspP31785
GTEx: &nbspENSG00000147168&nbsp
Entity Groups &nbsp
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP31785
Glycosylation
Glycosylation Sites: 3Go to GlyGen: P31785-1
Sequence Annotations
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 4
MoleculeChains Sequence LengthOrganismDetailsImage
Interleukin-2
D, H
133Homo sapiensMutation(s): 1&nbsp
Gene Names:&nbspIL2
UniProt & NIH Common Fund Data Resources
Find proteins for&nbspP60568&nbsp(Homo sapiens)
Explore&nbspP60568&nbsp
Go to UniProtKB: &nbspP60568
PHAROS: &nbspP60568
GTEx: &nbspENSG00000109471&nbsp
Entity Groups &nbsp
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP60568
Sequence Annotations
Expand
  • Reference Sequence
Oligosaccharides

Help

Entity ID: 5
MoleculeChains Length2D Diagram Glycosylation3D Interactions
beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
I, M
4N-Glycosylation
Glycosylation Resources
GlyTouCan: &nbspG32152BH
GlyCosmos: &nbspG32152BH
GlyGen: &nbspG32152BH
Entity ID: 6
MoleculeChains Length2D Diagram Glycosylation3D Interactions
alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose
J
2N-Glycosylation
Glycosylation Resources
GlyTouCan: &nbspG86851RC
GlyCosmos: &nbspG86851RC
GlyGen: &nbspG86851RC
Entity ID: 7
MoleculeChains Length2D Diagram Glycosylation3D Interactions
beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
K, O
3N-Glycosylation
Glycosylation Resources
GlyTouCan: &nbspG15407YE
GlyCosmos: &nbspG15407YE
GlyGen: &nbspG15407YE
Entity ID: 8
MoleculeChains Length2D Diagram Glycosylation3D Interactions
2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
L, P
2N-Glycosylation
Glycosylation Resources
GlyTouCan: &nbspG42666HT
GlyCosmos: &nbspG42666HT
GlyGen: &nbspG42666HT
Entity ID: 9
MoleculeChains Length2D Diagram Glycosylation3D Interactions
2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
N
3N-Glycosylation
Glycosylation Resources
GlyTouCan: &nbspG21290RB
GlyCosmos: &nbspG21290RB
GlyGen: &nbspG21290RB
Experimental Data & Validation

Experimental Data

  • Method:&nbspX-RAY DIFFRACTION
  • Resolution:&nbsp3.00 Å
  • R-Value Free:&nbsp 0.263 (Depositor), 0.220 (DCC)&nbsp
  • R-Value Work:&nbsp 0.220 (Depositor), 0.220 (DCC)&nbsp
  • R-Value Observed:&nbsp0.223&nbsp(Depositor)&nbsp
Space Group:&nbspP 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 57.266α = 83.85
b = 70.545β = 82.45
c = 129.236γ = 89.72
Software Package:
Software NamePurpose
REFMACrefinement
HKL-2000data reduction
SCALEPACKdata scaling
PHASERphasing

Structure Validation

View&nbspFull Validation Report



Ligand Structure Quality Assessment&nbsp


Entry History&nbsp

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2006-02-21
    Type: Initial release
  • Version 1.1: 2008-05-01
    Changes: Version format compliance
  • Version 1.2: 2011-07-13
    Changes: Advisory, Version format compliance
  • Version 2.0: 2020-07-29
    Type: Remediation
    Reason: Carbohydrate remediation
    Changes: Atomic model, Data collection, Database references, Derived calculations, Structure summary
  • Version 2.1: 2021-10-20
    Changes: Database references, Structure summary
  • Version 2.2: 2023-08-23
    Changes: Data collection, Refinement description
  • Version 2.3: 2024-10-30
    Changes: Structure summary